WHO Reports Escalating Ebola Outbreak in DRC, Exceeding 500 Deaths
Ebola continues to spread in DRC – The escalating crisis of the Bundibugyo strain of Ebola in the Democratic Republic of the Congo (DRC) has drawn urgent attention from the World Health Organization (WHO). On Tuesday, the organization confirmed that the epidemic is intensifying, with the government reporting a significant rise in confirmed cases. As of 4 July, the tally includes 1,561 infections, 506 fatalities, and 254 recoveries, underscoring the severity of the situation. Despite efforts to expedite testing and explore treatment avenues, the true extent of the outbreak remains unclear, according to WHO officials.
Dr. Anne Ancia: Uncertainty and Progress
Dr. Anne Ancia, the WHO’s representative in the DRC, emphasized the complexity of the outbreak’s current trajectory. “The true scale has not yet been fully established,” she stated, highlighting the challenges in tracking the virus’s spread. While the WHO aims to stabilize the situation, Dr. Ancia noted that definitive progress is still pending. “We would like to say it is stabilising, but frankly, we cannot say it yet,” she added, underscoring the need for continued vigilance.
“Today, we do not have enough ambulances.”
Dr. Ancia, speaking from Bunia, the capital of Ituri province, described the strain on local resources. She noted that treatment centers in the region are operating at full capacity, struggling to meet the demand. “I visited treatment centres in and around Bunia, Beni, Butembo, Katwa, and met frontline workers responsible for patient care, contact tracing, and community mobilization,” she shared. Her comments reflect both the dedication of healthcare workers and the logistical hurdles they face in combating the disease.
Testing Expansion and Strategic Measures
The WHO is collaborating closely with the DRC government to enhance testing capabilities and improve understanding of the transmission chain. Dr. Ancia explained that detailed case histories are being analyzed to map the spread of the virus and isolate potential contacts. “We are strengthening our understanding of the history of every case of infection so that we can really grasp the chain of transmission,” she said, stressing the importance of this data-driven approach.
A critical development in the response has been the decentralization of testing efforts. Daily testing capacity has surged from 30 in Kinshasa to over 2,000 tests per day, a feat made possible by the establishment of 10 regional laboratories in affected provinces. The most recent lab opened in Bunia, significantly boosting local diagnostic capabilities. “Thanks to these 10 decentralised laboratories, we’ve expanded our testing reach,” Dr. Ancia explained, highlighting how this infrastructure supports timely identification of cases and containment efforts.
“These drugs will be administered alone or in combination to assess their potential to improve survival among people with the Bundibugyo virus disease.”
Amid the growing cases, the WHO has also initiated a clinical trial to evaluate promising therapies. Starting on 2 July, the trial will test two treatments: the monoclonal antibody MBP134 and the antiviral remdesivir. These interventions aim to enhance survival rates for patients infected with the Bundibugyo species, which currently lacks a proven cure. “More than 1,200 treatment doses are available, and new therapies can be added to the trial as evidence emerges,” Dr. Ancia said, signaling optimism about the potential for breakthroughs.
Challenges in Conflict Zones
The outbreak is unfolding in areas plagued by ongoing conflict and limited healthcare infrastructure. Ituri province, a focal point of the epidemic, faces immense pressure from both the virus and the security situation. Dr. Ancia pointed out that heavy fighting between the Congolese Army (FARDC) and armed groups like the Wazalendo has strained medical services and hindered response operations. “The security situation in eastern DRC remains highly unstable,” she remarked, citing violent clashes in North Kivu, South Kivu, and Ituri provinces as a major obstacle.
James Swan, the head of the UN Stabilization Mission in the DRC (MONUSCO), provided further insight into the security dynamics. In late June, he told the Security Council that combat between the AFC/M23 militia and FARDC forces continues, with support from Rwanda and the Wazalendo group. This conflict has created conditions where healthcare workers operate in precarious environments, often having to navigate dangerous zones to reach patients.
“James Swan, head of the UN Stabilization Mission in the DRC, known as MONUSCO, told the Security Council that heavy fighting continues between the Alliance Fleuve Congo/23 March Movement (AFC/M23), supported by Rwandan forces, and the Congolese Army (FARDC) allied with the Wazalendo armed group.”
Despite these challenges, Dr. Ancia highlighted efforts to bolster community-based surveillance. In areas controlled by de facto authorities, such as parts of North Kivu, the WHO is working to ensure that no cases are overlooked. “We are working to strengthen community surveillance to make sure that there are no more cases,” she said, noting that daily alerts from field laboratories are critical to tracking the virus. “A high number of alerts are coming through every day from labs in the field and are being followed up,” she added, emphasizing the collaborative nature of the response.
When asked about claims by the AFC/M23 group that the virus had been eradicated in their territories, Dr. Ancia confirmed that no confirmed cases have been reported in those zones. “We have received information indicating that there are no more cases in those areas and all contact cases have been released,” she stated, offering reassurance while acknowledging the need for sustained monitoring. This development, she noted, could be a turning point in containing the outbreak, though vigilance remains essential.
As the situation evolves, the WHO continues to stress the importance of community engagement and resource allocation. “The dedication of staff who continue to serve their communities despite enormous challenges is remarkable,” Dr. Ancia said. With over 10,000 contacts being monitored and testing capacity expanding rapidly, there is hope that the outbreak can be brought under control. However, the road ahead remains fraught with obstacles, requiring coordinated efforts from both local and international actors.
